Chronic Ischemic Heart Disease. Chronic ischaemic heart disease, unspecified
Conditions
Interventions
Intervention 1: The Intervention Group Received A Total Of 60 Mg Of Nicorandil 20 Mg Tablets (Merck, USA) Orally In 3 Intervals
First Turn: 12 Hours Before Angiography, Second Turn: 3 Hours Before Angiography, And The Last Turn: 6 Hours After Angioplasty. The Patients Merely Underwent Angiography With No Need For Angioplasty W
Treatment - Drugs
The Intervention Group Received A Total Of 60 Mg Of Nicorandil 20 Mg Tablets (Merck, USA) Orally In 3 Intervals
The Control Group Received Isoshape, Isocolor And Isosmall Tablets (Merck, USA) Orally In 3 Intervals
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion Criteria: Chronic Stable Ischemic Heart Disease Which Were Candidated For Angiography And Probably Angioplasty Exclusion Criteria Included: History Of Heart Surgery; Having Branch Block With Qrs > 120 Miliseconds Or Complete Atrioventricular Block In ECG; Atrial Fibrillation; Renal Failure Or Electrolyte Abnormalities; Use Of Narcotics; No Need To Perform Angioplasty And Complications During Angioplasty (Acute Stent Thrombosis, Coronary Dissection, Adjacent Vessels Lost And No Reflow Of The Arteries).
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Difference In QTC Dispersion. Timepoint: 12 Hours Before And After Angioplasty. Method of measurement: By ECG IN Milliseconds. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNima Nakhaee
Mashad University of Medical Sciences
Outcome results
None listed